Molecular profiling — the comprehensive analysis of genes, RNAs and proteins — is having a radical effect on our understanding of cancer. The next step is to convert these findings into better diagnosis and treatment.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
*CNIO Symposium: The Molecular Taxonomy of Cancer. Madrid, Spain, 3–6 February 2004.
References
van't Veer, L. J. et al. Nature 415, 530–536 (2002).
Van de Vijver, M. J. et al. N. Engl. J. Med. 347, 1999–2009 (2002).
Alexe, G. et al. Proteomics 4, 766–783 (2004).
Futreal, P. A. et al. Nature Rev. Cancer 4, 177–183 (2004).
Stegmaier, K. et al. Nature Genet. 36, 257–263 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kallioniemi, O. Profile of a tumour. Nature 428, 379–381 (2004). https://doi.org/10.1038/428379b
Issue Date:
DOI: https://doi.org/10.1038/428379b
This article is cited by
-
Current potential and limitations of molecular diagnostic methods in head and neck cancer
European Archives of Oto-Rhino-Laryngology (2010)
-
Towards preventive medicine
EMBO reports (2008)